Bifunctional polynuclear platinum compounds represent a novel class of metal-based antitumor drugs which are currently undergoing preclinical development. A typical agent is [(trans-PtCl(NH(3))(2))(2)H(2)N(CH(2))(4)NH(2)]Cl(2) (1,1/t,t), which coordinates to bases in DNA and forms various types of covalent crosslinks. It also forms a 1,2-d(GpG) intrastrand adduct, the equivalent of the major DNA lesion of 'classical' cisplatin. In the present study differential scanning calorimetry and spectroscopic techniques were employed to characterize the influence of this crosslink on the thermal stability and energetics of 20 bp DNA duplexes site-specifically modified by 1,1/t,t. Thermal denaturation data revealed that the crosslink of 1,1/t,t reduced thermal and thermodynamical stability of the duplex noticeably more than that of 'classical' cisplatin. The energetic consequences of the intrastrand crosslink at the d(GG) site are discussed in relation to the structural distortions induced by this adduct in DNA and to its recognition and binding by HMG domain proteins. It has been suggested that the results of the present work are consistent with different DNA binding modes of cisplatin and polynuclear bifunctional DNA-binding drugs, which might be relevant to their distinct biological effectiveness.

Institute of Biophysics Academy of Sciences of the Czech Republic Královopolská 135 CZ 61265 Brno Czech Republic

Zobrazit více v PubMed

Rosenberg B. (1999) Platinum complexes for the treatment of cancer: why the search goes on? In Lippert,B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 3–30.

O’Dwyer P.J., Stevenson,J.P. and Johnson,S.W. (1999) Clinical status of cisplatin, carboplatin and other platinum-based antitumor drugs. In Lippert,B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 31–72.

Reedijk J. (1996) Improved understanding in platinum antitumour chemistry. Chem. Commun., 801–806.

Lepre C.A. and Lippard,S.J. (1990) Interaction of platinum antitumor compounds with DNA. Nucleic Acids Mol. Biol., 4, 9–38.

Johnson N.P., Butour,J.-L., Villani,G., Wimmer,F.L., Defais,M., Pierson,V. and Brabec,V. (1989) Metal antitumor compounds: the mechanism of action of platinum complexes. Prog. Clin. Biochem. Med., 10, 1–24.

Comess K.M., Burstyn,J.N., Essigmann,J.M. and Lippard,S.J. (1992) Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry, 31, 3975–3990. PubMed

Eastman A. (1999) The mechanism of action of cisplatin: from adducts to apoptosis. In Lippert,B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 111–134.

Jamieson E.R. and Lippard,S.J. (1999) Structure, recognition and processing of cisplatin-DNA adducts. Chem. Rev., 99, 2467–2498. PubMed

Zamble D.B. and Lippard,S.J. (1999) The response of cellular proteins to cisplatin-damaged DNA. In Lippert,B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zürich, Switzerland, pp. 73–110.

Farrell N. (2000) Polynuclear charged platinum compounds as a new class of anticancer agents—toward a new paradigm. In Farrell,N.P. and Kelland,L.R. (eds), Platinum-based Drugs in Cancer Therapy. Humana Press, Totowa, NJ, pp. 321–338.

Farrell N., Qu,Y., Bierbach,U., Valsecchi,M. and Menta,E. (1999) Structure-activity relationship within di- and trinuclear platinum phase I clinical agents. In Lippert,B. (ed.), Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH, Zurich, Switzerland, pp. 479–496.

Farrell N., Appleton,T.G., Qu,Y., Roberts,J.D., Fontes,A.P.S., Skov,K.A., Wu,P. and Zou,Y. (1995) Effects of geometric isomerism and ligand substitution in bifunctional dinuclear platinum complexes on binding properties and conformational changes in DNA. Biochemistry, 34, 15480–15486. PubMed

Zaludova R., Zakovska,A., Kasparkova,J., Balcarova,Z., Kleinwachter,V., Vrana,O., Farrell,N. and Brabec,V. (1997) DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. Eur. J. Biochem., 246, 508–517. PubMed

Kasparkova J., Mellish,K.J., Qu,Y., Brabec,V. and Farrell,N. (1996) Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Biochemistry, 35, 16705–16713. PubMed

Fichtinger-Schepman A.M.J., Van der Veer,J.L., Den Hartog,J.H.J., Lohman,P.H.M. and Reedijk,J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification and quantitation. Biochemistry, 24, 707–713. PubMed

Eastman A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther., 34, 155–166. PubMed

Bellon S.F. and Lippard,S.J. (1990) Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-Pt(NH3)2(N3-cytosine)Cl+. Biophys. Chem., 35, 179–188. PubMed

Takahara P.M., Frederick,C.A. and Lippard,S.J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J. Am. Chem. Soc., 118, 12309–12321.

Gelasco A. and Lippard,S.J. (1998) NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) adduct d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry, 37, 9230–9239. PubMed

Ohndorf U.M., Rould,M.A., He,Q., Pabo,C.O. and Lippard,S.J. (1999) Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature, 399, 708–712. PubMed

Pilch D.S., Plum,G.E. and Breslauer,K.J. (1995) The thermodynamics of DNA structures that contain lesions or guanine tetrads. Curr. Opin. Struct. Biol., 5, 334–342. PubMed

Plum G.E., Grollman,A.P., Johnson,F. and Breslauer,K.J. (1995) Influence of the oxidatively damaged adduct 8-oxodeoxyguanosine on the conformation, energetics and thermodynamic stability of a DNA duplex. Biochemistry, 34, 16148–16160. PubMed

Poklar N., Pilch,D.S., Lippard,S.J., Redding,E.A., Dunham,S.U. and Breslauer,K.J. (1996) Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability and energetics of a 20-mer DNA duplex. Proc. Natl Acad. Sci. USA, 93, 7606–7611. PubMed PMC

Pilch D.S., Dunham,S.U., Jamieson,E.R., Lippard,S.J. and Breslauer,K.J. (2000) DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link and the conformational and thermodynamic properties of duplex DNA. J. Mol. Biol., 296, 803–812. PubMed

Farrell N., Qu,Y., Feng,L. and Van Houten,B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry, 29, 9522–9531. PubMed

Brabec V., Reedijk,J. and Leng,M. (1992) Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry, 31, 12397–12402. PubMed

Brabec V. and Leng,M. (1993) DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl Acad. Sci. USA, 90, 5345–5349. PubMed PMC

Kasparkova J., Farrell,N. and Brabec,V. (2000) Sequence specificity, conformation and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. J. Biol. Chem., 275, 15789–15798. PubMed

Haynie D.T. (1998) Quantitative analysis of differential scanning calorimetric data. In Ladbury,J.E. and Chowdhry,B.Z. (eds), Biocalorimetry. Applications of Calorimetry in the Biological Sciences. John Wiley & Sons, Chichester, UK, pp. 183–205.

Hofr C. and Brabec,V. (2001) Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. J. Biol. Chem., 276, 9655–9661. PubMed

Malina J., Hofr,C., Maresca,L., Natile,G. and Brabec,V. (2000) DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands. Biophys. J., 78, 2008–2021. PubMed PMC

Bailly C., Gentle,D., Hamy,F., Purcell,M. and Waring,M.J. (1994) Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin. Biochem. J., 300, 165–173. PubMed PMC

Breslauer K.J., Frank,R., Blocker,H. and Marky,L.A. (1986) Predicting DNA duplex stability from the base sequence. Proc. Natl Acad. Sci. USA, 83, 3746–3750. PubMed PMC

Dunham S.U. and Lippard,S.J. (1997) DNA sequence context and protein composition modulate HMG-domain protein recognition of ciplatin-modified DNA. Biochemistry, 36, 11428–11436. PubMed

Kasparkova J. and Brabec,V. (1995) Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins. Biochemistry, 34, 12379–12387. PubMed

Brabec V. (2000) Chemistry and structural biology of 1,2-interstrand adducts of cisplatin. In Kelland,L.R. and Farrell,N.P. (eds), Platinum-based Drugs in Cancer Therapy. Humana Press, Totowa, NJ, pp. 37–61.

Processing and Bypass of a Site-Specific DNA Adduct of the Cytotoxic Platinum-Acridinylthiourea Conjugate by Polymerases Involved in DNA Repair: Biochemical and Thermodynamic Aspects

Thermodynamic stability and energetics of DNA duplexes containing major intrastrand cross-links of second-generation antitumor dinuclear Pt(II) complexes

Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair

Biophysical studies on the stability of DNA intrastrand cross-links of transplatin

Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog

Effects of monofunctional adducts of platinum(II) complexes on thermodynamic stability and energetics of DNA duplexes

DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent